ログイン

MAJOR LIPOPROTEINS
57問 • 2年前
  • Yves Laure Pimentel
  • 通報

    問題一覧

  • 1

    MAJOR LIPOPROTEINS ARE

    Chylomicrons (CM Very Low Density Lipoprotein/Pre-Beta Lipoprotein (VLDL) High density Lipoprotein/Alpha Lipoprotein (HDL)

  • 2

    Chylomicrons (CM)______and ______dense._________ TAG TRANSPORT

    LARGEST; LEAST; EXOGENOUS/ DIETARY

  • 3

    Chylomicrons (CM) Apolipoproteins:

    Apo-B 48

  • 4

    Chylomicrons (CM) delivers TAG in?

    TISSUE AND LIVER

  • 5

    Very Low Density Lipoprotein/Pre-Beta Lipoprotein (VLDL) ____________TAG Transport

    ENDOGENOUS

  • 6

    are secreted into the blood by the liver for metabolism in peripheral tissues.

    Very Low Density Lipoprotein/Pre-Beta Lipoprotein (VLDL)

  • 7

    Very Low Density Lipoprotein/Pre-Beta Lipoprotein (VLDL) Apolipoproteins:

    Apo B-100

  • 8

    what VLDL stimulates?

    FATS AND CARBOHYDRATES

  • 9

    High density Lipoprotein/Alpha Lipoprotein (HDL) synthesized in the ?

    INTESTINES and liver cells

  • 10

    HDL molecules are RECYCLED? molecules

    chylomicron and VLDL

  • 11

    High density Lipoprotein/Alpha Lipoprotein (HDL)______and ______dense

    SMALLEST AND MOST

  • 12

    REVERSE cholesterol Transport

    High density Lipoprotein/Alpha Lipoprotein (HDL)

  • 13

    HDL maintains the ________of cholesterol

    EQUILIBRIUM

  • 14

    HDL Apolipoproteins:

    Apo A-1

  • 15

    Prevents build up of cholesterol in Blood Vessel

    ANTI ATHEROGENIC

  • 16

    Three Step Procedure: accepted reference method for HDL-C developed at the CDC.

    ● 1.Ultracentrifugation: ● 2.Heparin Manganese: ● 3.Supernatant Analysis by Abell-Kendall assay

  • 17

    Supernatant Analysis by ? WHICH IS FOUND IN THE?

    Abell-Kendall assay HDL

  • 18

    1.Ultracentrifugation: IS?

    TO REMOVE VLDL

  • 19

    2.Heparin Manganese: IS?

    TO REMOVE LDL

  • 20

    HDL Reference value:

    40 mg/dL (cutoff level)

  • 21

    EXAMPLES OF STEROID HORMONES

    CORTISOL ALDOSTERONES

  • 22

    <35mg/dL IN HDL

    – high risk for CHD

  • 23

    – high risk for CHD IN HDL

    <35mg/dL

  • 24

    ≥60 mg/dL IN HDL

    high (protective)

  • 25

    high (protective) IN HDL

    ≥60 mg/dL

  • 26

    MAJOR cholesterol carrier and transports a large amount of endogenous cholesterol

    Low Density Lipoprotein/Beta Lipoprotein (LDL)

  • 27

    Low Density Lipoprotein/Beta Lipoprotein (LDL) most __________lipoprotein

    ATHEROGENIC

  • 28

    Low Density Lipoprotein/Beta Lipoprotein (LDL) .____________cholesterol pathway

    FORWARD

  • 29

    FORWARD cholesterol pathway

    Low Density Lipoprotein/Beta Lipoprotein (LDL) .

  • 30

    LDL Apolipoproteins

    Apo B-100

  • 31

    LDL –C is currently considered the most important value in assessing _________risk

    CARDIAC

  • 32

    is currently considered the most important value in assessing CARDIAC risk

    LDL –C

  • 33

    Formula For LDL – Cholesterol (LDL-C) =

    TC-HDL-VLDL

  • 34

    Friedewald Method (indirect method) METHOD SHORTCUT

    TC-HDL-TAG/5 OR 2.175

  • 35

    Friedewald Method (indirect method ⇒ indirect, not valid for triglycerides over ____mg/dL)

    400

  • 36

    Friedewald Method (indirect method) VLDL (mmol/L) =Plasma TAG/?

    2.175

  • 37

    Friedewald Method (indirect method) VLDL (mg/dL) =Plasma TAG/ ?

    5

  • 38

    Low Density Lipoprotein/Beta Lipoprotein (LDL) 2 METHODS

    Friedewald Method (indirect method) De Long Method (indirect method)

  • 39

    De Long Method (indirect method) ⇒ VLDL (mmol/L) = Plasma TAG/?

    2.825

  • 40

    De Long Method (indirect method ⇒ VLDL (mg/dL) =Plasma TAG/

    6.5

  • 41

    Reference values <100 mg/dL =

    optimal

  • 42

    Reference values = optimal

    <100 mg/dL

  • 43

    Reference values 100 -129 mg/dL =

    near/above optimal

  • 44

    Reference values = near/above optimal

    100 -129 mg/dL

  • 45

    Reference values 130-159 mg/dL =

    borderline high

  • 46

    Reference values = borderline high

    130-159 mg/dL

  • 47

    Reference values 160-189 mg/dL =

    high

  • 48

    Reference values = high

    160-189 mg/dL

  • 49

    Reference values ≥190 mg/dL =

    very high

  • 50

    Reference values = very high

    ≥190 mg/dL

  • 51

    is the target medications for patient with CHD

    LDL-C

  • 52

    LDL-C is the target medications for patient with

    CHD

  • 53

    NCEP (?)

    NATIONAL CHOLESTEROL EDUCATION PROGRAM

  • 54

    Total cholesterol __% CV

    3

  • 55

    HDL-C (≥42mg/dL) __%CV

    4

  • 56

    LDL-C ___% CV

    4

  • 57

    TAG ___% CV

    5

  • other names parasitology

    other names parasitology

    Yves Laure Pimentel · 70問 · 2年前

    other names parasitology

    other names parasitology

    70問 • 2年前
    Yves Laure Pimentel

    PARASITOLOGY

    PARASITOLOGY

    Yves Laure Pimentel · 111問 · 2年前

    PARASITOLOGY

    PARASITOLOGY

    111問 • 2年前
    Yves Laure Pimentel

    HTMLBE

    HTMLBE

    Yves Laure Pimentel · 64問 · 2年前

    HTMLBE

    HTMLBE

    64問 • 2年前
    Yves Laure Pimentel

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    Yves Laure Pimentel · 61問 · 2年前

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    61問 • 2年前
    Yves Laure Pimentel

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    Yves Laure Pimentel · 69問 · 2年前

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    69問 • 2年前
    Yves Laure Pimentel

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    Yves Laure Pimentel · 100問 · 2年前

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    100問 • 2年前
    Yves Laure Pimentel

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    Yves Laure Pimentel · 41問 · 2年前

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    41問 • 2年前
    Yves Laure Pimentel

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    Yves Laure Pimentel · 87問 · 2年前

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    87問 • 2年前
    Yves Laure Pimentel

    CSF 1

    CSF 1

    Yves Laure Pimentel · 100問 · 2年前

    CSF 1

    CSF 1

    100問 • 2年前
    Yves Laure Pimentel

    CSF 2

    CSF 2

    Yves Laure Pimentel · 82問 · 2年前

    CSF 2

    CSF 2

    82問 • 2年前
    Yves Laure Pimentel

    SEMEN 1

    SEMEN 1

    Yves Laure Pimentel · 100問 · 2年前

    SEMEN 1

    SEMEN 1

    100問 • 2年前
    Yves Laure Pimentel

    SEMEN 2

    SEMEN 2

    Yves Laure Pimentel · 7問 · 2年前

    SEMEN 2

    SEMEN 2

    7問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    Yves Laure Pimentel · 100問 · 2年前

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    100問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    Yves Laure Pimentel · 6問 · 2年前

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    6問 • 2年前
    Yves Laure Pimentel

    SEROUS FLUID

    SEROUS FLUID

    Yves Laure Pimentel · 25問 · 2年前

    SEROUS FLUID

    SEROUS FLUID

    25問 • 2年前
    Yves Laure Pimentel

    PLEURAL FLUID

    PLEURAL FLUID

    Yves Laure Pimentel · 44問 · 2年前

    PLEURAL FLUID

    PLEURAL FLUID

    44問 • 2年前
    Yves Laure Pimentel

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    Yves Laure Pimentel · 18問 · 2年前

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    18問 • 2年前
    Yves Laure Pimentel

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    Yves Laure Pimentel · 30問 · 2年前

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    30問 • 2年前
    Yves Laure Pimentel

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    Yves Laure Pimentel · 92問 · 2年前

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    92問 • 2年前
    Yves Laure Pimentel

    FECALYSIS

    FECALYSIS

    Yves Laure Pimentel · 80問 · 2年前

    FECALYSIS

    FECALYSIS

    80問 • 2年前
    Yves Laure Pimentel

    問題一覧

  • 1

    MAJOR LIPOPROTEINS ARE

    Chylomicrons (CM Very Low Density Lipoprotein/Pre-Beta Lipoprotein (VLDL) High density Lipoprotein/Alpha Lipoprotein (HDL)

  • 2

    Chylomicrons (CM)______and ______dense._________ TAG TRANSPORT

    LARGEST; LEAST; EXOGENOUS/ DIETARY

  • 3

    Chylomicrons (CM) Apolipoproteins:

    Apo-B 48

  • 4

    Chylomicrons (CM) delivers TAG in?

    TISSUE AND LIVER

  • 5

    Very Low Density Lipoprotein/Pre-Beta Lipoprotein (VLDL) ____________TAG Transport

    ENDOGENOUS

  • 6

    are secreted into the blood by the liver for metabolism in peripheral tissues.

    Very Low Density Lipoprotein/Pre-Beta Lipoprotein (VLDL)

  • 7

    Very Low Density Lipoprotein/Pre-Beta Lipoprotein (VLDL) Apolipoproteins:

    Apo B-100

  • 8

    what VLDL stimulates?

    FATS AND CARBOHYDRATES

  • 9

    High density Lipoprotein/Alpha Lipoprotein (HDL) synthesized in the ?

    INTESTINES and liver cells

  • 10

    HDL molecules are RECYCLED? molecules

    chylomicron and VLDL

  • 11

    High density Lipoprotein/Alpha Lipoprotein (HDL)______and ______dense

    SMALLEST AND MOST

  • 12

    REVERSE cholesterol Transport

    High density Lipoprotein/Alpha Lipoprotein (HDL)

  • 13

    HDL maintains the ________of cholesterol

    EQUILIBRIUM

  • 14

    HDL Apolipoproteins:

    Apo A-1

  • 15

    Prevents build up of cholesterol in Blood Vessel

    ANTI ATHEROGENIC

  • 16

    Three Step Procedure: accepted reference method for HDL-C developed at the CDC.

    ● 1.Ultracentrifugation: ● 2.Heparin Manganese: ● 3.Supernatant Analysis by Abell-Kendall assay

  • 17

    Supernatant Analysis by ? WHICH IS FOUND IN THE?

    Abell-Kendall assay HDL

  • 18

    1.Ultracentrifugation: IS?

    TO REMOVE VLDL

  • 19

    2.Heparin Manganese: IS?

    TO REMOVE LDL

  • 20

    HDL Reference value:

    40 mg/dL (cutoff level)

  • 21

    EXAMPLES OF STEROID HORMONES

    CORTISOL ALDOSTERONES

  • 22

    <35mg/dL IN HDL

    – high risk for CHD

  • 23

    – high risk for CHD IN HDL

    <35mg/dL

  • 24

    ≥60 mg/dL IN HDL

    high (protective)

  • 25

    high (protective) IN HDL

    ≥60 mg/dL

  • 26

    MAJOR cholesterol carrier and transports a large amount of endogenous cholesterol

    Low Density Lipoprotein/Beta Lipoprotein (LDL)

  • 27

    Low Density Lipoprotein/Beta Lipoprotein (LDL) most __________lipoprotein

    ATHEROGENIC

  • 28

    Low Density Lipoprotein/Beta Lipoprotein (LDL) .____________cholesterol pathway

    FORWARD

  • 29

    FORWARD cholesterol pathway

    Low Density Lipoprotein/Beta Lipoprotein (LDL) .

  • 30

    LDL Apolipoproteins

    Apo B-100

  • 31

    LDL –C is currently considered the most important value in assessing _________risk

    CARDIAC

  • 32

    is currently considered the most important value in assessing CARDIAC risk

    LDL –C

  • 33

    Formula For LDL – Cholesterol (LDL-C) =

    TC-HDL-VLDL

  • 34

    Friedewald Method (indirect method) METHOD SHORTCUT

    TC-HDL-TAG/5 OR 2.175

  • 35

    Friedewald Method (indirect method ⇒ indirect, not valid for triglycerides over ____mg/dL)

    400

  • 36

    Friedewald Method (indirect method) VLDL (mmol/L) =Plasma TAG/?

    2.175

  • 37

    Friedewald Method (indirect method) VLDL (mg/dL) =Plasma TAG/ ?

    5

  • 38

    Low Density Lipoprotein/Beta Lipoprotein (LDL) 2 METHODS

    Friedewald Method (indirect method) De Long Method (indirect method)

  • 39

    De Long Method (indirect method) ⇒ VLDL (mmol/L) = Plasma TAG/?

    2.825

  • 40

    De Long Method (indirect method ⇒ VLDL (mg/dL) =Plasma TAG/

    6.5

  • 41

    Reference values <100 mg/dL =

    optimal

  • 42

    Reference values = optimal

    <100 mg/dL

  • 43

    Reference values 100 -129 mg/dL =

    near/above optimal

  • 44

    Reference values = near/above optimal

    100 -129 mg/dL

  • 45

    Reference values 130-159 mg/dL =

    borderline high

  • 46

    Reference values = borderline high

    130-159 mg/dL

  • 47

    Reference values 160-189 mg/dL =

    high

  • 48

    Reference values = high

    160-189 mg/dL

  • 49

    Reference values ≥190 mg/dL =

    very high

  • 50

    Reference values = very high

    ≥190 mg/dL

  • 51

    is the target medications for patient with CHD

    LDL-C

  • 52

    LDL-C is the target medications for patient with

    CHD

  • 53

    NCEP (?)

    NATIONAL CHOLESTEROL EDUCATION PROGRAM

  • 54

    Total cholesterol __% CV

    3

  • 55

    HDL-C (≥42mg/dL) __%CV

    4

  • 56

    LDL-C ___% CV

    4

  • 57

    TAG ___% CV

    5